Lobe Sciences Ltd.
LOBE
CNSX
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.85% | 62.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.04% | 57.83% | |||
| Operating Income | 5.04% | -57.83% | |||
| Income Before Tax | 15.58% | 71.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.58% | 71.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.58% | 71.84% | |||
| EBIT | 5.04% | -57.83% | |||
| EBITDA | 5.07% | -52.62% | |||
| EPS Basic | 23.53% | 71.90% | |||
| Normalized Basic EPS | 9.52% | -40.00% | |||
| EPS Diluted | 23.53% | 71.90% | |||
| Normalized Diluted EPS | 9.52% | -40.00% | |||
| Average Basic Shares Outstanding | 7.29% | 1.63% | |||
| Average Diluted Shares Outstanding | 7.29% | 1.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||